Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 135

1.

Corrigendum to 'A report on the status of vaccination in Europe' [Vaccine 36 (2018) 4979-4992].

Sheikh S, Biundo E, Courcier S, Damm O, Launay O, Maes E, Marcos C, Matthews S, Meijer C, Poscia A, Postma M, Saka O, Szucs T, Begg N.

Vaccine. 2019 Feb 28;37(10):1374-1376. doi: 10.1016/j.vaccine.2019.01.038. Epub 2019 Feb 4. No abstract available.

2.

Oral Modified Release Multiple-Unit Particulate Systems: Compressed Pellets, Microparticles and Nanoparticles.

Al-Hashimi N, Begg N, Alany RG, Hassanin H, Elshaer A.

Pharmaceutics. 2018 Oct 4;10(4). pii: E176. doi: 10.3390/pharmaceutics10040176. Review.

3.

A report on the status of vaccination in Europe.

Sheikh S, Biundo E, Courcier S, Damm O, Launay O, Maes E, Marcos C, Matthews S, Meijer C, Poscia A, Postma M, Saka O, Szucs T, Begg N.

Vaccine. 2018 Aug 9;36(33):4979-4992. doi: 10.1016/j.vaccine.2018.06.044. Epub 2018 Jul 4. Review. Erratum in: Vaccine. 2019 Feb 28;37(10):1374-1376.

4.

Ethical Considerations for the Participation of Children of Minor Parents in Clinical Trials.

Ott MA, Crawley FP, Sáez-Llorens X, Owusu-Agyei S, Neubauer D, Dubin G, Poplazarova T, Begg N, Rosenthal SL.

Paediatr Drugs. 2018 Jun;20(3):215-222. doi: 10.1007/s40272-017-0280-y.

5.

Outside in - inside out. Creating focus on the patient - a vaccine company perspective.

Sohy D, Dusart I, Goulet P, Visy D, Gasthuys L, Poplazarova T, Breuer T, Begg N.

Hum Vaccin Immunother. 2018 Jun 3;14(6):1509-1514. doi: 10.1080/21645515.2018.1428510. Epub 2018 Feb 15. Review.

6.

Audible frequency vibration of puncture-access medical devices.

Begg ND, Slocum AH.

Med Eng Phys. 2014 Mar;36(3):371-7. doi: 10.1016/j.medengphy.2013.12.011. Epub 2014 Jan 1.

PMID:
24387905
7.

Classroom to Clinic: Merging Education and Research to Efficiently Prototype Medical Devices.

Hanumara NC, Begg ND, Walsh C, Custer D, Gupta R, Osborn LR, Slocum AH.

IEEE J Transl Eng Health Med. 2013 Jul 24;1:4700107. doi: 10.1109/JTEHM.2013.2271897. eCollection 2013.

8.

Trust in Vaccines: Why It Takes More than Good Faith.

Begg N.

Vaccines (Basel). 2013 Aug 12;1(3):343-7. doi: 10.3390/vaccines1030343.

9.

Safety profile of trocar and insufflation needle access systems in laparoscopic surgery.

Passerotti CC, Begg N, Penna FJ, Passerotti AM, Leite KR, Antunes AA, Srougi M, Retik AB, Nguyen HT.

J Am Coll Surg. 2009 Aug;209(2):222-32. doi: 10.1016/j.jamcollsurg.2009.03.022. Epub 2009 May 28.

PMID:
19632599
10.

A novel combined Hib-MenC-TT glycoconjugate vaccine as a booster dose for toddlers: a phase 3 open randomised controlled trial.

Pace D, Snape M, Westcar S, Oluwalana C, Yu LM, Begg N, Wysocki J, Czajka H, Maechler G, Boutriau D, Pollard AJ.

Arch Dis Child. 2008 Nov;93(11):963-70. doi: 10.1136/adc.2007.136036. Epub 2008 May 7.

PMID:
18463125
11.

A new combination haemophilus influenzae type B and Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine for primary immunization of infants.

Pace D, Snape M, Westcar S, Hamaluba M, Yu LM, Begg N, Wysocki J, Czajka H, Maechler G, Boutriau D, Pollard AJ.

Pediatr Infect Dis J. 2007 Nov;26(11):1057-9.

PMID:
17984816
12.

Immunogenicity, reactogenicity, and immune memory after primary vaccination with a novel Haemophilus influenzae-Neisseria meningitidis serogroup C conjugate vaccine.

Schmitt HJ, Maechler G, Habermehl P, Knuf M, Saenger R, Begg N, Boutriau D.

Clin Vaccine Immunol. 2007 Apr;14(4):426-34. Epub 2007 Feb 7.

13.

Estimating the burden of serogroup C meningococcal disease in England and Wales.

Davison KL, Ramsay ME, Crowcroft NS, Lieftucht A, Kaczmarski EB, Trotter CL, Gungabissoon U, Begg NT.

Commun Dis Public Health. 2002 Sep;5(3):213-9.

PMID:
12434691
14.

Enhanced surveillance scheme for suspected meningococcal disease in five regional health authorities in England: 1998.

Davison KL, Crowcroft NS, Ramsay ME, Begg NT, Kaczmarski EB, Stuart JM, White JM, Orr H; Enhanced Surveillance of Meningococcal Disease Project Group.

Commun Dis Public Health. 2002 Sep;5(3):205-12. Erratum in: Commun Dis Public Health. 2002 Dec;5(4):343..

PMID:
12434690
15.

Overview: epidemiology, surveillance, and population biology.

Maiden MC, Begg NT.

Methods Mol Med. 2001;67:121-30. doi: 10.1385/1-59259-149-3:121.

PMID:
21337141
16.

Induction of immunological memory in UK infants by a meningococcal A/C conjugate vaccine.

Borrow R, Fox AJ, Richmond PC, Clark S, Sadler F, Findlow J, Morris R, Begg NT, Cartwright KA.

Epidemiol Infect. 2000 Jun;124(3):427-32.

17.
18.

Meningococcal disease and healthcare workers.

Pollard AJ, Begg N.

BMJ. 1999 Oct 30;319(7218):1147-8. No abstract available.

19.

Salivary antibodies following parenteral immunization of infants with a meningococcal serogroup A and C conjugated vaccine.

Borrow R, Fox AJ, Cartwright K, Begg NT, Jones DM.

Epidemiol Infect. 1999 Oct;123(2):201-8.

20.

Policies for public health management of meningococcal disease.

Begg N.

J Epidemiol Community Health. 1999 Sep;53(9):516. No abstract available.

21.

Neutralising antibody responses to two doses of measles vaccine at 5 and 13 months of age in the United Kingdom.

Ko B, Roberts D, Begg N, Rao M, Teare L, Cohen B.

Commun Dis Public Health. 1999 Sep;2(3):203-6.

PMID:
10491877
22.

Consensus statement on diagnosis, investigation, treatment and prevention of acute bacterial meningitis in immunocompetent adults. British Infection Society Working Party.

Begg N, Cartwright KA, Cohen J, Kaczmarski EB, Innes JA, Leen CL, Nathwani D, Singer M, Southgate L, Todd WT, Welsby PD, Wood MJ.

J Infect. 1999 Jul;39(1):1-15. Review. No abstract available.

PMID:
10468122
23.

Immunogenicity and reactogenicity in UK infants of a novel meningococcal vesicle vaccine containing multiple class 1 (PorA) outer membrane proteins.

Cartwright K, Morris R, Rümke H, Fox A, Borrow R, Begg N, Richmond P, Poolman J.

Vaccine. 1999 Jun 4;17(20-21):2612-9.

PMID:
10418910
24.

Meningococcal serogroup C conjugate vaccine is immunogenic in infancy and primes for memory.

Richmond P, Borrow R, Miller E, Clark S, Sadler F, Fox A, Begg N, Morris R, Cartwright K.

J Infect Dis. 1999 Jun;179(6):1569-72.

PMID:
10228085
25.

Meningitis in wales

Begg N, Gregor S.

BMJ. 1999 Feb 20;318(7182):544. No abstract available.

26.
27.

Lone parent families are an independent risk factor for lower rates of childhood immunisation in London.

Sharland M, Atkinson P, Maguire H, Begg N.

Commun Dis Rep CDR Rev. 1997 Oct 17;7(11):R169-72.

PMID:
9350095
28.

Vaccine failures after primary immunisation with Haemophilus influenzae type-b conjugate vaccine without booster.

Booy R, Heath PT, Slack MP, Begg N, Moxon ER.

Lancet. 1997 Apr 26;349(9060):1197-202. Erratum in: Lancet 1997 May 31;349(9065):1630.

PMID:
9130940
29.

Conjugate meningococcal serogroup A and C vaccine: reactogenicity and immunogenicity in United Kingdom infants.

Fairley CK, Begg N, Borrow R, Fox AJ, Jones DM, Cartwright K.

J Infect Dis. 1996 Dec;174(6):1360-3.

PMID:
8940235
30.

A cluster of cases of streptococcal necrotizing fasciitis in Gloucestershire.

Cartwright K, Logan M, McNulty C, Harrison S, George R, Efstratiou A, McEvoy M, Begg N.

Epidemiol Infect. 1995 Dec;115(3):387-97. Erratum in: Epidemiol Infect 1996 Jun;116(3):383.

31.

Diphtheria: are we ready for it?

Begg N, Balraj V.

Arch Dis Child. 1995 Dec;73(6):568-72. Review. No abstract available.

32.
33.

The new requirements for communicable disease training.

Begg N.

J Public Health Med. 1995 Sep;17(3):364. No abstract available.

PMID:
8527194
34.

Epidemiology of invasive Haemophilus influenzae infections in England and Wales in the pre-vaccination era (1990-2).

Anderson EC, Begg NT, Crawshaw SC, Hargreaves RM, Howard AJ, Slack MP.

Epidemiol Infect. 1995 Aug;115(1):89-100.

35.

Will London's COVER meet the target?

Sharland M, Atkinson P, Maguire H, White J, Begg N.

Commun Dis Rep CDR Rev. 1995 Mar 31;5(4):R53. No abstract available.

PMID:
7735350
36.

Pneumococcal bacteraemia and meningitis in England and Wales 1982 to 1992.

Aszkenasy OM, George RC, Begg NT.

Commun Dis Rep CDR Rev. 1995 Mar 31;5(4):R45-50.

PMID:
7735348
37.

A collaborative case control study of sporadic hepatitis A in England.

Maguire HC, Handford S, Perry KR, Nicholas S, Waight P, Parry JV, O'Mahony M, Begg NT.

Commun Dis Rep CDR Rev. 1995 Mar 3;5(3):R33-40. Review.

PMID:
7536590
38.

Avidity of specific IgG antibodies elicited by immunisation against Haemophilus influenzae type b.

Agbarakwe AE, Griffiths H, Begg N, Chapel HM.

J Clin Pathol. 1995 Mar;48(3):206-9.

39.

Initial management of suspected meningococcal infection. Parenteral benzylpenicillin is vital.

Cartwright K, Levin M, Begg N.

BMJ. 1994 Dec 17;309(6969):1660-1. No abstract available.

40.

Antibody response and viral excretion after live polio vaccine or a combined schedule of live and inactivated polio vaccines.

Ramsay ME, Begg NT, Gandhi J, Brown D.

Pediatr Infect Dis J. 1994 Dec;13(12):1117-21.

PMID:
7892081
41.

Myths in medicine. Immunisation.

Begg N, Nicoll A.

BMJ. 1994 Oct 22;309(6961):1073-5. Review. No abstract available.

42.

Fast-tracking meningococcal vaccination.

Fairley CK, White JM, Begg NT.

Lancet. 1994 Oct 22;344(8930):1164-5. No abstract available.

PMID:
7934525
43.

Efficacy of Hib vaccine.

Teare EL, Fairley CK, White J, Begg NT.

Lancet. 1994 Sep 17;344(8925):828-9. No abstract available.

PMID:
7916111
44.

Tetanus: delay in diagnosis in England and Wales.

Schon F, O'Dowd L, White J, Begg N.

J Neurol Neurosurg Psychiatry. 1994 Aug;57(8):1006-7.

45.

Immunoprophylaxis at extremes of age.

Begg NT.

J Antimicrob Chemother. 1994 Aug;34 Suppl A:121-8. Review.

PMID:
7844068
46.

COVER (cover of vaccination evaluated rapidly): 30.

White JM, Leon S, Begg NT.

Commun Dis Rep CDR Rev. 1994 Jun 24;4(7):R82. No abstract available.

PMID:
7520804
47.

Systemic allergic reactions to Japanese encephalitis vaccines.

Nazareth B, Levin J, Johnson H, Begg N.

Vaccine. 1994 May;12(7):666. No abstract available.

PMID:
8085387
48.

Primary immunisations in Liverpool.

Salisbury DM, Begg N.

Arch Dis Child. 1994 Apr;70(4):355-6. No abstract available.

49.

'COVER' (cover of vaccination evaluated rapidly): 29.

White JM, Leon S, Begg NT.

Commun Dis Rep CDR Rev. 1994 Apr 1;4(4):R51-2. No abstract available.

PMID:
7514926
50.

'COVER' (cover of vaccination evaluated rapidly): 28.

White JM, Leon S, Begg NT.

Commun Dis Rep CDR Rev. 1994 Feb 4;4(2):R18-9. No abstract available.

PMID:
7511461

Supplemental Content

Support Center